The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts on the Latest FDA Decision The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The Pharmacology of Longevity: Peptide Edition (Part 1)